SBRT Combined With Fruquintinib Plus PD-1/CTLA-4 Antibody for Third-line Treatment in mCRC
Clinical trial NCT05747716 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05747716
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-28
- Primary completion
- 2026-12-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.